Myasthenia Gravis Panel 2

The Myasthenia Gravis Panel 2 test contains 1 test with 3 biomarkers.

Myasthenia Gravis is a neurological disorder characterized by a decrease in acetylcholine receptors. Patients exhibit skeletal muscle weakness and fatigability. Approximately 80% of patients with Myasthenia Gravis, excluding ocular involvement only, have detectable acetylcholine receptor antibody.

Acetylcholine Receptor Binding Antibody
Acetylcholine Receptor Blocking Antibody
Acetylcholine Receptor Modulating Antibody

  • No Prescription Needed
  • Discounts up to 80%
  • Hundreds of Lab Tests Available

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Anti-striated Muscle Antibody

Acetylcholine Receptor

Acetylcholine Receptor

Acetylcholine Receptor

Search by Zip Code

No Results Found

There are no results that match the search criteria submitted.
Please change the criteria and try again.